contains over 60 omics data sets contributed by the international C. elegans research community. Patient registries such as those developed for MVID [3] , Dystrophic EB, and CHARGE syndrome enable clinicians to enter data about patient phenotypes and causal mutations. MOL-GENIS/omx most recent application is to facilitate interpretation of the massive amounts of genomics data, including eQTL pathogenicity predictions, and/or clinical interpretation of NGS data in research consortia and clinical labs. 
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